U.S. FDA approves Revance’s wrinkle treatment

This advertisement has not loaded yet, but your article continues below. Author of the article: Article content Revance Therapeutics said on Thursday it has received the U.S. Food and Drug Administration’s Financial Post Top Stories Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc. By clicking…
U.S. FDA approves Revance’s wrinkle treatment

Author of the article:

Article content

Revance Therapeutics said on

Thursday it has received the U.S. Food and Drug Administration’s

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

approval for its injection to treat wrinkles that appear as

people become older.

(Reporting by Leroy Leo in Bengaluru)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Chevron can resume key role in Venezuela’s oil output, exports
Read More

Chevron can resume key role in Venezuela’s oil output, exports

Author of the article: Reuters Daphne Psaledakis and Marianna Parraga Publishing date: Nov 26, 2022  •  13 hours ago  •  4 minute read Join the conversation WASHINGTON/HOUSTON — Chevron Corp on Saturday received a U.S. license allowing the second-largest U.S. oil company to expand its production in Venezuela and bring the South American country’s crude oil…